BioArctic AB
STO:BIOA B

Watchlist Manager

BioArctic AB

STO:BIOA B

Watchlist

Dividends

Price: 195.8 SEK 29.33% Market Closed

Market Cap: 17.3B SEK

Have any thoughts about
BioArctic AB?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 195.8 SEK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

BIOA B Alert

BioArctic AB

195.8

+44.4 (+29.33%)

52 Week Range	139.9 277.4
Price Target

We'll email you a reminder when the closing price reaches SEK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

BioArctic AB

What unique competitive advantages
does BioArctic AB hold over its rivals?

What risks and challenges
does BioArctic AB face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of BioArctic AB.

What unique competitive advantages
does BioArctic AB hold over its rivals?

What risks and challenges
does BioArctic AB face in the near future?

Summarize the latest earnings call
of BioArctic AB.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for BioArctic AB.

Provide P/S
for BioArctic AB.

Provide P/E
for BioArctic AB.

Provide P/OCF
for BioArctic AB.

Provide P/FCFE
for BioArctic AB.

Provide P/B
for BioArctic AB.

Provide EV/S
for BioArctic AB.

Provide EV/GP
for BioArctic AB.

Provide EV/EBITDA
for BioArctic AB.

Provide EV/EBIT
for BioArctic AB.

Provide EV/OCF
for BioArctic AB.

Provide EV/FCFF
for BioArctic AB.

Provide EV/IC
for BioArctic AB.

Show me price targets
for BioArctic AB made by professional analysts.

What are the Revenue projections
for BioArctic AB?

How accurate were the past Revenue estimates
for BioArctic AB?

What are the Net Income projections
for BioArctic AB?

How accurate were the past Net Income estimates
for BioArctic AB?

What are the EPS projections
for BioArctic AB?

How accurate were the past EPS estimates
for BioArctic AB?

What are the EBIT projections
for BioArctic AB?

How accurate were the past EBIT estimates
for BioArctic AB?

Compare the revenue forecasts
for BioArctic AB with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of BioArctic AB and its key competitors using the latest financial data.

Compare historical revenue growth rates
of BioArctic AB against its competitors.

Analyze the profit margins
(gross, operating, and net) of BioArctic AB compared to its peers.

Compare the P/E ratios
of BioArctic AB against its peers.

Discuss the investment returns and shareholder value creation
comparing BioArctic AB with its peers.

Analyze the financial leverage
of BioArctic AB compared to its main competitors.

Show all profitability ratios
for BioArctic AB.

Provide ROE
for BioArctic AB.

Provide ROA
for BioArctic AB.

Provide ROIC
for BioArctic AB.

Provide ROCE
for BioArctic AB.

Provide Gross Margin
for BioArctic AB.

Provide Operating Margin
for BioArctic AB.

Provide Net Margin
for BioArctic AB.

Provide FCF Margin
for BioArctic AB.

Show all solvency ratios
for BioArctic AB.

Provide D/E Ratio
for BioArctic AB.

Provide D/A Ratio
for BioArctic AB.

Provide Interest Coverage Ratio
for BioArctic AB.

Provide Altman Z-Score Ratio
for BioArctic AB.

Provide Quick Ratio
for BioArctic AB.

Provide Current Ratio
for BioArctic AB.

Provide Cash Ratio
for BioArctic AB.

What is the historical Revenue growth
over the last 5 years for BioArctic AB?

What is the historical Net Income growth
over the last 5 years for BioArctic AB?

What is the current Free Cash Flow
of BioArctic AB?

Discuss the annual earnings per share (EPS)
trend over the past five years for BioArctic AB.

EV/EBITDA
Enterprise Value to EBITDA

-142.1

Current

-37

Median

4.3

Industry

Lower than median

Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA

-142.1

Enterprise Value

13.6B SEK

EBITDA

-96m SEK

All Countries

Forward Multiples

			Market Cap	EV/EBITDA
SE		BioArctic AB STO:BIOA B	14.1B SEK	-142.1
FR		Pharnext SCA OTC:PNEXF	6T USD	-216 796.7
US		Abbvie Inc NYSE:ABBV	300.2B USD	14.8
US		Amgen Inc NASDAQ:AMGN	159.1B USD	17.5
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	126.6B USD	26.7
US		Gilead Sciences Inc NASDAQ:GILD	114.6B USD	10.1
US	E	Epizyme Inc F:EPE	94.1B EUR	-521.2
AU		CSL Ltd ASX:CSL	137.3B AUD	20.8
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	87.6B USD	17.3
US	S	Seagen Inc F:SGT	39.3B EUR	-59.5
NL		argenx SE XBRU:ARGX	34.1B EUR	-104.5

				EBITDA Growth
SE		BioArctic AB STO:BIOA B	Average EV/EBITDA: 17.9 Negative Multiple: -142.1	270%
FR		Pharnext SCA OTC:PNEXF	Negative Multiple: -216 796.7	N/A
US		Abbvie Inc NYSE:ABBV	14.8	28%
US		Amgen Inc NASDAQ:AMGN	17.5	63%
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	26.7	38%
US		Gilead Sciences Inc NASDAQ:GILD	10.1	12%
US	E	Epizyme Inc F:EPE	Negative Multiple: -521.2	N/A
AU		CSL Ltd ASX:CSL	20.8	42%
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	17.3	46%
US	S	Seagen Inc F:SGT	Negative Multiple: -59.5	N/A
NL		argenx SE XBRU:ARGX	Negative Multiple: -104.5	N/A

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/EBITDA

-55.8

2-Years Forward

EV/EBITDA

43.4

3-Years Forward

EV/EBITDA

13.6

BioArctic AB
STO:BIOA B

EV/EBITDA
Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

BioArctic AB STO:BIOA B

EV/EBITDA Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

BioArctic AB
STO:BIOA B

EV/EBITDA
Enterprise Value to EBITDA